Robert Takeuchi

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Part of Agylis SAS, RT Consulting SAS is a French company that provides business software design and consultancy services. The company is based in Paris, France.

Part of SoftBank Group Corp., Softbank Finance America Corp. is an American company.

Credit Suisse First Boston LLC provides global investment banking services in the United States. It provides private banking and financial advisory services and banking products. Its businesses include securities underwriting, sales & trading, investment banking, private equity, alternative assets, financial advisory services, investment research and asset management. It is headquartered in New York, NY.

SBI Investment Co., Ltd. (SBI Investment) is a venture capital subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp.

Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA.